TX-TECH-MAHINDRA
22.2.2021 14:31:07 CET | Business Wire | Press release
Tech Mahindra Ltd., one of the fastest growing Global IT companies and a leading provider of digital transformation, consulting and business re-engineering services and solutions, today announced the launch of a first-of-its-kind phygital (physical and digital) Global Chess League. It also announced that Viswanathan Anand, five-time World Chess Champion, and Indian Chess Grandmaster will mentor, partner, advise and help shape the league. With his motivational and inspirational stature across the world as an individual and a chess champion, Anand will help catalyse the growth of chess, further building the sport that has defined his entire life as he joins hands with the Tech Mahindra Global Chess League and becomes its face for the global audience and his fans.
The League’s launch will mark a watershed moment as it aims to raise the profile of the sport, discover new generations of chess champions, enhance the fan base of the sport and take the sport to new commercial heights. New-age technologies such as 5G, artificial intelligence, and virtual reality will be at the core and will be leveraged to explore innovative ways of promoting the game through interactive platforms to engage a global audience. Tech Mahindra will act as the architect behind this concept and will provide necessary operational and technological support to execute the vision.
Anand Mahindra, Chairman, Mahindra Group, said, “Chess still has an incipient and largely untapped potential across the globe. Recently, there has been a surge of interest post the online Chess Olympiad and the enormous popularity of a TV series based on the game. We hope that the creation of a league will harness this resurgence of interest and bring about a renaissance in the world of chess. I am particularly excited about sharing my learnings from founding the Pro Kabaddi league with the team in order to replicate that success on a much larger and global platform.”
Viswanathan Anand, 5-time World Chess Champion, said , “Chess is a game that is played by millions around the world. At this time, a unique opportunity exists to popularize it further and dramatically enhance its visibility through a global league powered by technology. I am personally happy to partner with a technology provider like Tech Mahindra, whose endorsement and promotion will certainly elevate the sport to a higher level and offer the right platform to popularize chess across the globe. There is a renewed interest in the game of chess and through this unique global league format, we will be able to keep the spirit of chess intact and ensure the right platform is provided to upcoming talent.”
Current plans envision the League to engage players from all levels – professional or otherwise. The League will have 8 franchise owned teams from across the world. The teams will comprise of a mix of titled women and men players along with juniors and wildcard entrants playing each other in a Round Robin format. The teams qualifying for the semifinals will enter the knockout stage of the championship. We are actively looking at the prospect of introducing innovative scoring, board selection methods and a fantasy league to maximize viewer engagement. The final League structure and team details will be announced in due course.
CP Gurnani, MD & CEO, Tech Mahindra, said, “Chess has many synergies with the business world, with its emphasis on intellect, strategy and mental rigor. By leveraging Tech Mahindra’s expertise in new age technologies like 5G and Virtual Reality to drive fan engagement and viewership globally, we can truly transform chess into an e-sport. Furthermore, this global chess league will help us create an exceptional and inspirational experience by bringing the game home to global fans.”
As part of its NXT.NOW framework, which aims to enhance ‘Human Centric Experience’, Tech Mahindra has a deep focus on leveraging cutting-edge technologies to deliver enhanced experience and enable digital transformation to meet the evolving needs of the customer.
About Viswanathan Anand
As a five-time World Chess Champion, Viswanathan Anand has cemented his place among the greatest Champions of all times. His hallmark lightning speed and intuitive play is well recognized and critics rate him as one of the biggest natural talents ever in the history of chess. He is the only champion in chess history to have won a World championship title in all formats, match, knock-out and tournament. In India he has received the high civilian awards of Padma Vibhushan, Padma Bhushan, Padma Shri and Arjuna Award. He is also the first recipient of the Rajiv Gandhi Khel Ratna Award. He is also a six-time winner of the coveted “Chess Oscars.”
About Tech Mahindra
Tech Mahindra offers innovative and customer-centric digital experiences, enabling enterprises, associates and the society to Rise. We are a USD 5.2 billion organization with 121,900+ professionals across 90 countries helping 997 global customers, including Fortune 500 companies. We are focused on leveraging next-generation technologies including 5G, Blockchain, Cybersecurity, Artificial Intelligence, and more, to enable end-to-end digital transformation for global customers. Tech Mahindra is one of the fastest growing brands and amongst the top 15 IT service providers globally. Tech Mahindra has consistently emerged as a leader in sustainability and is recognized amongst the ‘2021 Global 100 Most sustainable corporations in the World’ by Corporate Knights. With the NXT.NOW framework, Tech Mahindra aims to enhance ‘Human Centric Experience’ for our ecosystem and drive collaborative disruption with synergies arising from a robust portfolio of companies. We aim at delivering tomorrow’s experiences today, and believe that the ‘Future is Now’.
We are part of the Mahindra Group, a USD 19.4 billion federation of companies that enables people to rise through innovative mobility solutions, driving rural prosperity, enhancing urban living, nurturing new businesses and fostering communities. It enjoys a leadership position in utility vehicles, information technology, financial services and vacation ownership in India and is the world’s largest tractor company by volume. It also enjoys a strong presence in renewable energy, agribusiness, logistics and real estate development. Headquartered in India, Mahindra employs over 2, 56,000 people across 100 countries.
Connect with us on www.techmahindra.com
Our Social Media Channels
Facebook: https://www.facebook.com/TechMahindra
Twitter: https://twitter.com/Tech_Mahindra
LinkedIn: https://www.linkedin.com/company/tech-mahindra/
YouTube: https://www.youtube.com/user/techmahindra09
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005512/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom